Focused cardiac ultrasound is defined as the use of US at the bedside in order to evaluate the unstable patient and, within a specific list of diagnoses, to individualize clinical treatment for a particular situation based on ultrasound findings and with the use of binary and qualitative questions (yes/no ---much/little). 5 It is important, however, to emphasize its difference when compared to formal echocardiographic examination.
The single purpose of focused cardiac ultrasound is to give answer to qualitative questions, being used as a complement to the physical examination in a short time and with a defined objective of evaluating the cause of clinical instability based on a specific list of diagnoses (Table 1) , and its intraoperative use by the anesthesiologist is related to lower rates of complications and mortality in high-risk patients. 6 On the other hand, the formal echocardiographic examination, however abridged it may be, is dependent on an operator trained, enabled, and certified in the acquisition, analysis, and interpretation of the images obtained, in addition to being often used in different clinical situations besides those found in the perioperative period 7 (Table 2) . 
Formal echocardiography
Training and qualification in the acquisition and interpretation of images Advanced knowledge in the use of US technology
Focused cardiac US
Specific and limited objective Basic knowledge on the use of US and its perioperative application
The literature shows that its management is quickly learned and easily acquired, 8 but it needs to be continually practiced. 9 The question that now arises is how to incorporate this skill in our field if there is no formal model of anesthesiologist training, capacitation, and certification, whether during residency or already professionally active. 8 Ideally, POCUS training should be done in the same way as those used for cardiovascular anesthesiologist training in transesophageal perioperative echocardiography, 9 based on a robust program composed of theoretical classes, training in simulators and living models.
It is time for the anesthesiologist to explore and further incorporate this ability with the use of ultrasound and add it to those already mastered (peripheral blocks, venous accesses) in order to ally the use of this technology to better care for patients in general and, particularly, for severely ill patients.
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A written consent form was obtained from the patients before procedure. Case was an 18 year-old man, who underwent giant lipoma excision (23 cm × 10 cm × 5 cm) on the axillary region (Fig. 1A and B) . The latissimus dorsi and the serratus muscles were visualized at the level of 4th and 5th ribs on the posterior-axillary line. With the in-plane technique, a 100 mm sonovisible nerve block needle was advanced between the latissimus dorsi and the serratus muscles planes in a caudal to the cranial direction. Two mL saline injection was made to confirm the position of the needle, and 15 mL 0.5% bupivacaine and 15 mL 2% lidocaine injection
